These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11858735)

  • 1. Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures: a model to explain the potency of the aromatic retinoid (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzoic acid.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 2002 Feb; 178(3):186-94. PubMed ID: 11858735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):319-27. PubMed ID: 9070355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1999 Sep; 159(2):109-16. PubMed ID: 10495774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid receptor gamma-induced misregulation of chondrogenesis in the murine limb bud in vitro.
    Galdones E; Hales BF
    Toxicol Sci; 2008 Nov; 106(1):223-32. PubMed ID: 18703560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells.
    Wouters W; van Dun J; Dillen A; Coene MC; Cools W; De Coster R
    Cancer Res; 1992 May; 52(10):2841-6. PubMed ID: 1581897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of TGF-beta 2 to inhibition of limb bud chondrogenesis by retinoid in rats.
    Tsuiki H; Fukiishi Y; Kishi K
    Teratology; 1996 Oct; 54(4):191-7. PubMed ID: 9122888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.
    Benbrook DM; Madler MM; Spruce LW; Birckbichler PJ; Nelson EC; Subramanian S; Weerasekare GM; Gale JB; Patterson MK; Wang B; Wang W; Lu S; Rowland TC; DiSivestro P; Lindamood C; Hill DL; Berlin KD
    J Med Chem; 1997 Oct; 40(22):3567-83. PubMed ID: 9357524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonal carcinoma cell lines stably transfected with mRARbeta2-lacZ: sensitive system for measuring levels of active retinoids.
    Sonneveld E; van den Brink CE; van der Leede BJ; Maden M; van der Saag PT
    Exp Cell Res; 1999 Aug; 250(2):284-97. PubMed ID: 10413584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific antagonist of retinoid toxicity in mice.
    Standeven AM; Johnson AT; Escobar M; Chandraratna RA
    Toxicol Appl Pharmacol; 1996 May; 138(1):169-75. PubMed ID: 8658506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
    Flanagan JL; Willhite CC; Ferm VH
    J Natl Cancer Inst; 1987 Mar; 78(3):533-8. PubMed ID: 3469465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative developmental toxicity potencies of retinoids in the embryonic stem cell test compared with their relative potencies in in vivo and two other in vitro assays for developmental toxicity.
    Louisse J; Gönen S; Rietjens IM; Verwei M
    Toxicol Lett; 2011 May; 203(1):1-8. PubMed ID: 21362465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous status of retinoids and their cytosolic binding proteins in limb buds of chick vs mouse embryos.
    Scott WJ; Walter R; Tzimas G; Sass JO; Nau H; Collins MD
    Dev Biol; 1994 Oct; 165(2):397-409. PubMed ID: 7958408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.
    Van Wauwe J; Van Nyen G; Coene MC; Stoppie P; Cools W; Goossens J; Borghgraef P; Janssen PA
    J Pharmacol Exp Ther; 1992 May; 261(2):773-9. PubMed ID: 1374473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of high dysmorphogenic activity of Ro 13-6307, a tetramethylated tetralin analog of retinoic acid.
    Kochhar DM; Penner JD
    Teratology; 1992 Jun; 45(6):637-45. PubMed ID: 1412056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of retinoids on cartilage differentiation in micromass cultures of chick facial primordia and the relationship to a specific facial defect.
    Wedden SE; Lewin-Smith MR; Tickle C
    Dev Biol; 1987 Jul; 122(1):78-89. PubMed ID: 3596013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural characterization of normal and abnormal chondrogenesis in micromass rat embryo limb bud cell cultures.
    Renault JY; Caillaud JM; Chevalier J
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):177-87. PubMed ID: 7871531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
    Willhite CC; Dubois A; Schindler-Horvat J; Apfel C; Eckhoff C
    Teratology; 1995 Sep; 52(3):169-75. PubMed ID: 8638257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
    Kochhar DM; Penner JD; Minutella LM
    Drug Metab Dispos; 1989; 17(6):618-24. PubMed ID: 2575497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of a new series of retinoidal benzoic acid derivatives as measured by induction of differentiation of murine F9 teratocarcinoma cells and human HL-60 promyelocytic leukemia cells.
    Strickland S; Breitman TR; Frickel F; Nürrenbach A; Hädicke E; Sporn MB
    Cancer Res; 1983 Nov; 43(11):5268-72. PubMed ID: 6577946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.